Dr. Cesar Gentille is an assistant professor at the Department of Hematology at the University of Arkansas Medical Sciences (UAMS) in Little Rock, Arkansas. His clinical focus is on malignant hematology, including hematopoietic cell transplant and cellular therapy. His field of interest is lymphoproliferative disorders, particularly T-cell neoplasms. In CTCL, he is the point person from his department who treats these patients alongside the dermatology clinic team.
His research includes retrospective data analysis of outcomes in PCTL and CTCL. Currently, He is a PI/co-investigator in different clinical trials in lymphomas, including phase I and phase II studies.
🏥 University Affiliation, City, Country: University of Arkansas for Medical Sciences (UAMS), Little Rock, Arkansas, US
🧪 Area of focus in clinical practice and research: Lymphomas, including PTCL and CTCL
🔎 Looking forward to in the field of cutaneous lymphomas and at the 6th WCCL:
I am particularly interested in innovative therapeutic approaches for CTCL and the evolving impact of hematopoietic stem cell transplantation.
💭 What are you passionate about in medicine or recreationally? In medicine, I enjoy teaching and mentoring trainees—medical students, residents, and fellows—particularly through collaborative research projects. Recreationally, I enjoy cooking, which I find relaxing, staying active at the gym, and I am a big movie fan with a particular interest in true crime.
🏆 A short story or academic achievement you are proud of: I am most proud of the work we have done to open clinical trials at UAMS. Expanding patient access to innovative therapies—especially for rare diseases such as T-cell lymphomas—allows patients to receive cutting-edge care without leaving the state, minimizing disruption to their lives and helping preserve quality of life.
🌟 Secret to career success: Persistence, along with the ability to learn from one’s own shortcomings and from the experiences of colleagues.